Viking Global Investors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $451M | Sell |
|
|||||
|
2025
Q2 | $676M | Buy |
|
|||||
|
2025
Q1 | $763M | Buy |
|
|||||
|
2024
Q4 | $691M | Buy |
|
|||||
|
2024
Q3 | $686M | Buy |
|
|||||
|
2024
Q2 | $582M | Buy |
|
|||||
|
2024
Q1 | $560M | Buy |
|
|||||
|
2023
Q4 | $471M | Buy |
|
|||||
|
2023
Q3 | $373M | Buy |
|
|||||
|
2023
Q2 | $360M | Buy |
|
|||||
|
2023
Q1 | $211M | Sell |
|
|||||
|
2022
Q4 | $546M | Buy |
|
|||||
|
2022
Q3 | $432M | Buy |
|
|||||
|
2022
Q2 | $419M | Buy |
|
|||||
|
2022
Q1 | $289M | Buy |
|
|||||
|
2021
Q4 | $254M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $123M | Sell |
|
|||||
|
2019
Q4 | $137M | Sell |
|
|||||
|
2019
Q3 | $206M | Buy |
|
|||||
|
2019
Q2 | $222M | Sell |
|
|||||
|
2019
Q1 | $456M | Buy |
|
|||||
|
2018
Q4 | $434M | Buy |
|
|||||
|
2018
Q3 | $400M | Buy |
|
|||||
|
2018
Q2 | $307M | Buy |
|
|||||
|
2018
Q1 | $136M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $23.6M | Sell |
|
|||||
|
2017
Q1 | $76.9M | Sell |
|
|||||
|
2016
Q4 | $116M | Buy |
|
|||||
|
2016
Q3 | $45.4M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $49.7M | Buy |
|